Advertisement

Topics

Clinical Trials About "QIAGEN" RSS

11:42 EDT 22nd October 2017 | BioPortfolio

We list hundreds of Clinical Trials about "QIAGEN" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "QIAGEN" on BioPortfolio

We have published hundreds of QIAGEN news stories on BioPortfolio along with dozens of QIAGEN Clinical Trials and PubMed Articles about QIAGEN for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of QIAGEN Companies in our database. You can also find out about relevant QIAGEN Drugs and Medications on this site too.

Showing "QIAGEN" Clinical Trials, all 3

Relevant

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infection and high-grade CIN lesions in a screening population of women 30 years of age or older in Germany.


Probably Relevant

Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)

Source: Sample bank of Xijing Hospital and Children's Hospital Affiliated to Soochow University; Sample form: Whole blood; Estimated number of samples: 100 patients with ADHD and age, sex matched healthy controls; Case exclusion criteria: all kinds of neuropsychiatric disorders, IQ value of less than 70; Study protocol: 1. Using Qiagen kit to extract the genomic DNA of 200 microliters of blood. 2. UV spectrophotometer test DNA purity of 260/280 close to 1.8 (1.8 ±...

GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps

Colorectal cancer ist the 2nd most leading cancer among men and women in germany. Screening colonoscopy has the potential to detect premalignant lesions. By endoscopical resection of these lesions, colorectal cancers could be avoided. The decision for surveillance is made according to patients medical history, amount and histological characteristics of the resected polyps. Molecular guided decisions are still missing. Thus, further tools and mechanisms, beyond but in addition t...



More From BioPortfolio on "QIAGEN"

Quick Search
Advertisement